Top Stories

AstraZeneca stock climbs on reports Trump could fast-track COVID-19 vaccine

0


AstraZeneca is developing a potential coronavirus vaccine in partnership with the University of Oxford.


stringer/Reuters

AstraZeneca
AZN,
+3.49%

stock rose more than 3% early on Monday, following reports President Donald Trump is considering fast-tracking the drugmaker’s coronavirus vaccine candidate, in a bid to make it available to Americans before the November election.

One option being looked at by the Trump administration would see the U.S. Food and Drug Administration award the potential vaccine “emergency use authorization” (EUA) in October, the…



Source marketwatch.com

China e-commerce boosted by shift to online shopping after coronavirus

Previous article

‘I really can’t explain it’

Next article

You may also like

Leave a Reply

avatar
  Subscribe  
Notify of

More in Top Stories